Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Busulfan × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 31 Myelodysplastic Syndromes 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia 8 Hematologic Neoplasms 8 Anemia, Refractory, with Excess of Blasts 8 Myeloproliferative Disorders 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Hodgkin Disease 7 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Graft vs Host Disease 5 Primary Myelofibrosis 4 Neuroblastoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Myeloid 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precancerous Conditions 3 Lymphoproliferative Disorders 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphoid 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Anemia, Aplastic 3 Wilms Tumor 2 Sarcoma, Ewing 2

Interventions

repotrectinib 1 pralsetinib 1 ONC206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡